Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.

Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis. - 2020


English

0009-7322

10.1161/CIRCULATIONAHA.119.044703 [doi] NIHMS1591512 [mid] PMC7301778 [pmc]


*Adrenal Cortex Hormones/ad [Administration & Dosage]
*Adrenal Cortex Hormones/ae [Adverse Effects]
*Immune Checkpoint Inhibitors/ad [Administration & Dosage]
*Immune Checkpoint Inhibitors/ae [Adverse Effects]
*Myocarditis/ci [Chemically Induced]
*Myocarditis/di [Diagnosis]
Cardiovascular Diseases/ci [Chemically Induced]
Cardiovascular Diseases/di [Diagnosis]
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Registries
Retrospective Studies


MedStar Heart & Vascular Institute


Letter

Powered by Koha